International Immunopharmacology,
Journal Year:
2024,
Volume and Issue:
136, P. 112367 - 112367
Published: May 31, 2024
SLC25A19
is
a
mitochondrial
thiamine
pyrophosphate
(TPP)
carrier
that
mediates
TPP
entry
into
the
mitochondria.
has
been
recognized
to
play
crucial
role
in
many
metabolic
diseases,
but
its
cancer
not
clearly
reported.
Based
on
clinical
data
from
The
Cancer
Genome
Atlas
(TCGA),
following
parameters
were
analyzed
among
HCC
patients:
expression,
enrichment
analyses,
immune
infiltration,
ferroptosis
and
prognosis
analyses.
In
vitro,
high
expression
was
validated
by
qRT-PCR
Immunohistochemistry.
Subsequently,
series
of
cell
function
experiments,
including
CCK8,
EdU,
clone
formation,
trans-well
scratch
assays,
conducted
illustrate
effect
growth
metastasis
cells.
Meanwhile,
indicators
related
also
detected.
SCL25A19
highly
expressed
predicts
poor
prognosis.
Elevated
patients
markedly
associated
with
T
stage,
pathological
status
(PS),
tumor
(TS),
histologic
grade
(HG),
AFP.
Our
results
indicate
generally
good
predictive
diagnostic
ability.
gene
analyses
showed
significantly
correlated
fatty
acid
metabolism,
marker
genes.
vitro
experiments
have
confirmed
silencing
can
inhibit
proliferation
migration
ability
cells
induce
HCC.
conclusion,
these
findings
novel
prognostic
biomarker
invasion
HCC,
it
an
excellent
candidate
for
therapeutic
target
against
Nature Cell Biology,
Journal Year:
2024,
Volume and Issue:
26(5), P. 825 - 838
Published: April 11, 2024
Abstract
Blocking
the
import
of
nutrients
essential
for
cancer
cell
proliferation
represents
a
therapeutic
opportunity,
but
it
is
unclear
which
transporters
to
target.
Here
we
report
CRISPR
interference/activation
screening
platform
systematically
interrogate
contribution
nutrient
support
in
environments
ranging
from
standard
culture
media
tumours.
We
applied
this
identify
amino
acids
leukaemia
cells
and
found
that
acid
transport
involves
high
bidirectional
flux
dependent
on
microenvironment
composition.
While
investigating
role
cystine
starved
cells,
uncovered
serotonin
uptake
preventing
ferroptosis.
Finally,
identified
subcutaneous
tumours
levels
glucose
can
restrain
environment.
This
study
establishes
framework
identifying
critical
cellular
transporters,
characterizing
their
function
exploring
how
tumour
impacts
metabolism.
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: March 21, 2024
Background
Multiple
sclerosis
(MS)
is
the
most
common
chronic
inflammatory
disease
of
central
nervous
system.
Currently,
pathological
mechanisms
MS
are
not
fully
understood,
but
research
has
suggested
that
iron
metabolism
disorder
may
be
associated
with
onset
and
clinical
manifestations
MS.
Methods
materials
The
study
utilized
publicly
available
databases
bioinformatics
techniques
for
gene
expression
data
analysis,
including
differential
weighted
correlation
network
enrichment
construction
logistic
regression
models.
Subsequently,
Mendelian
randomization
was
used
to
assess
causal
relationship
between
different
markers
Results
This
identified
IREB2,
LAMP2,
ISCU,
ATP6V1G1,
ATP13A2,
SKP1
as
genes
multiple
metabolism,
establishing
their
multi-gene
diagnostic
value
an
AUC
0.83.
Additionally,
analysis
revealed
a
potential
transferrin
saturation
(p=2.22E-02;
OR
95%CI=0.86
(0.75,
0.98)),
well
serum
(p=2.18E-04;
95%CI=1.22
(1.10,
1.36)).
Conclusion
comprehensively
explored
through
integrated
methods.
findings
provide
important
insights
further
into
role
in
pathogenesis
offer
crucial
theoretical
support
treatment
Scientific Reports,
Journal Year:
2024,
Volume and Issue:
14(1)
Published: Nov. 3, 2024
Cardiovascular
diseases
(CVDs)
are
complex,
multifactorial
conditions
that
require
personalized
assessment
and
treatment.
Advancements
in
multi-omics
technologies,
namely
RNA
sequencing
whole-genome
sequencing,
have
provided
translational
researchers
with
a
comprehensive
view
of
the
human
genome.
The
efficient
synthesis
analysis
this
data
through
integrated
approach
characterizes
genetic
variants
alongside
expression
patterns
linked
to
emerging
phenotypes,
can
reveal
novel
biomarkers
enable
segmentation
patient
populations
based
on
risk
factors.
In
study,
we
present
cutting-edge
methodology
rooted
integration
traditional
bioinformatics,
classical
statistics,
multimodal
machine
learning
techniques.
Our
has
potential
uncover
intricate
mechanisms
underlying
CVD,
enabling
patient-specific
response
profiling.
We
sourced
transcriptomic
single
nucleotide
polymorphisms
(SNPs)
from
both
CVD
patients
healthy
controls.
By
integrating
these
datasets
clinical
demographic
information,
generated
profiles.
Utilizing
robust
feature
selection
approach,
identified
signature
27
features
SNPs
effective
predictors
CVD.
Differential
analysis,
combined
minimum
redundancy
maximum
relevance
selection,
highlighted
explain
disease
phenotype.
This
prioritizes
biological
efficiency
learning.
employed
Combination
Annotation
Dependent
Depletion
scores
allele
frequencies
identify
pathogenic
characteristics
patients.
Classification
models
trained
demonstrated
high-accuracy
predictions
for
best
performing
was
an
XGBoost
classifier
optimized
via
Bayesian
hyperparameter
tuning,
which
able
correctly
classify
all
our
test
dataset.
Using
SHapley
Additive
exPlanations,
created
assessments
patients,
offering
further
contextualization
setting.
Across
cohort,
RPL36AP37
HBA1
were
scored
as
most
important
predicting
CVDs.
A
literature
review
revealed
substantial
portion
diagnostic
previously
been
associated
framework
propose
study
is
unbiased
generalizable
other
disorders.
Nature Communications,
Journal Year:
2023,
Volume and Issue:
14(1)
Published: March 30, 2023
Abstract
Autosomal
dominant
polycystic
kidney
disease
(ADPKD)
is
the
most
prevalent
potentially
lethal
monogenic
disorder.
Mutations
in
PKD1
gene,
which
encodes
polycystin-1
(PC1),
account
for
approximately
78%
of
cases.
PC1
a
large
462-kDa
protein
that
undergoes
cleavage
its
N
and
C-terminal
domains.
produces
fragments
translocate
to
mitochondria.
We
show
transgenic
expression
corresponding
final
200
amino
acid
(aa)
residues
two
Pkd1
-KO
orthologous
murine
models
ADPKD
suppresses
cystic
phenotype
preserves
renal
function.
This
suppression
depends
upon
an
interaction
between
tail
mitochondrial
enzyme
Nicotinamide
Nucleotide
Transhydrogenase
(NNT).
modulates
tubular/cyst
cell
proliferation,
metabolic
profile,
function,
redox
state.
Together,
these
results
suggest
short
fragment
sufficient
suppress
open
door
exploration
gene
therapy
strategies
ADPKD.